C4orf54

Across TCGA pan-cancer cohorts, C4orf54 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated C4orf54 data layer compared with 23 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher C4orf54 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated C4orf54 expression acts as an unfavorable survival marker.

LUAD and HNSC are the cancer types where C4orf54 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.223	0.764	.004	20	view →
HNSC	DFS	Tertile	All	0.880	1.000	.014	13	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

C4orf54–LUAD (OS)

Open the LUAD breakdown →